CDK-TCIP2

Product Description: DK-TCIP2, linking inhibitor of CDK9 SNS-032 (HY-10008) with ligands of BCL6 BI-3812 (HY-111381), is a anticancer agent. DK-TCIP2 shows anticancer activity in vivo and in vitro and can be used for study of lymphoma cancer[1].

Applications: Cancer-Kinase/protease

Formula: C52H67ClN12O8S2

References: [1]Sarott RC, et al. Relocalizing transcriptional kinases to activate apoptosis. Science. 2024 Oct 4;386(6717):eadl5361.

Molecular Weight: 1087.75

Compound Purity: 98.94

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: BCL6;CDK

• SKU: MEXHY-169245-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-169245-10
• Package Unit: 10 mg
• Quantity Unit: STK